Check out the companies that made the biggest moves at noon: Nike — The sneaker giant’s stock rose about 4% as board members Tim Cook and Robert Holmes Swann and Nike CEO Elliot Hill increased their stakes, Verity data shows. The move comes as Nike is wrapping up a tough year. Corcept Therapeutics — Shares plunged 50% after the U.S. Food and Drug Administration did not approve Corcept’s drug lilacorilant as a treatment for patients with hypercortisolism. The FDA determined that it could not reach a useful risk assessment for the drug unless the company provided further evidence of efficacy. Molina Healthcare — The insurance company rose 2.7%, marking its fourth consecutive positive session and rising 6.3% for the week. Molina received a boost this week after celebrity investor Michael Varley highlighted the company in a Substack post. Nvidia — The chipmaker rose 0.7%, adding to its stellar gains this year. Heading into 2025, Nvidia is up 40%. Vanda Pharmaceuticals — The biopharmaceutical company soared 25% after the FDA approved tradipitant, a drug aimed at treating motion-induced vomiting. Taiwan Semiconductor Manufacturing Co. – Shares rose 2% after Reuters reported that Nvidia asked the semiconductor company to increase production in the 2000s to meet orders from China for more than 2 million units in 2026. Hyatt Hotels – The hotel chain fell more than 1% after updating its 2025 outlook in the wake of Hurricane Melissa, which hit Jamaica in October. The company said it expects adjusted EBITDA to be at the low end of a range of $1.09 billion to $1.11 billion. — CNBC’s Darla Mercado, Liz Napolitano and Alex Harring contributed reporting.
